Horizon Pharma is a specialty and generic drug manufacturing company. The company is focused on the identification, development, acquisition, and commercialization of differentiated and accessible medicines that address unmet medical needs. The overwhelming majority of revenue is generated in the United States. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
| Website: | www.horizonpharma.com |
| Email: | investor-relations@horizonpharma.com |
| Main Phone: | +353 17722100 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House, 1st Floor |
| City / Town: | Dublin 4 |
| Country: | IRL |
| Postal Code: | D04 C5Y6 |
| Exchange: | NGS |
| CEO: | Timothy P. Walbert |
| Employees: | 1000 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Gathering Data... Please wait Horizon Pharma is a specialty and generic drug manufacturing company. The company is focused on the identification, development, acquisition, and commercialization of differentiated and accessible medicines that address unmet medical needs. The overwhelming majority of revenue is generated in the United States. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
| Website: | www.horizonpharma.com |
| Email: | investor-relations@horizonpharma.com |
| Main Phone: | +353 17722100 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House, 1st Floor |
| City / Town: | Dublin 4 |
| Country: | IRL |
| Postal Code: | D04 C5Y6 |
| Exchange: | NGS |
| CEO: | Timothy P. Walbert |
| Employees: | 1000 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 25.35 | Change $ 0.01 | Change % 0.04 | Tick N/A |
| Bid 25.33 | Bid Size 300.00 | Ask 25.35 | Ask Size 100.00 |
| Open 25.36 | High 25.51 | Low 24.95 | Prev Close 25.34 |
| Last Trade | Volume 190,517 | 52 Wk Hi 29.44 | 52 Wk Low 14.89 |
| Market Cap 4.7 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 184,883,881.00 | EPS (TTM) 0.30 | PE Ratio 84.50 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 36 | 64 |
| Number of Buys | 18 | 32 |
| Number of Sells | 18 | 32 |
| Net Activity | 242822 | 343770 |
| Last 10 Buys | Shares |
|---|---|
| Michael G. Grey | 1,000 |
| H. Thomas Watkins | 1,000 |
| H. Thomas Watkins | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Brian K. Beeler | 1,000 |
| Brian K. Beeler | 1,000 |
| Timothy P. Walbert | 1,000 |
| Brian K. Beeler | 1,000 |
| Robert F. Carey | 1,000 |
| Robert F. Carey | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Virinder Nohria | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 24 | 24 | 24 | 24 |
| Low Target Price Estimate | 16 | 16 | 16 | 16 |
| Mean Target Price Estimate | 20 | 20 | 20 | 20 |
| Standard Deviation | 3.21 | 3.21 | 3.21 | 3.21 |
| Date of Most Recent Estimate | 05/22/18 | 05/22/18 | 05/22/18 | 05/22/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| CT ORDER | 1 | 2018-05-14 | |
| S-8 | Securities offered to employees under employee benefit plans | 10 | 2018-05-11 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 112 | 2018-05-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 20 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1.29 | 1.29 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
